Rank;Global Rank;Institution;Country;Sector
1;23;Google Inc, USA;USA;Companies
2;108;Novartis Institutes for Biomedical Research, United States;USA;Companies
3;110;Hoffmann-La Roche Ltd, United States;USA;Companies
4;112;Regeneron Pharmaceuticals Inc;USA;Companies
5;116;Genentech Inc;USA;Companies
6;139;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
7;143;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
8;144;Foundation Medicine Inc;USA;Companies
9;157;Bristol-Myers Squibb Company, United States;USA;Companies
10;184;Janssen Biotech Inc;USA;Companies
11;188;Biogen Idec, USA;USA;Companies
12;194;Gilead Sciences Inc, United States;USA;Companies
13;200;Sanofi, United States;USA;Companies
14;227;Philips Research, Eindhoven;NLD;Companies
15;228;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
16;229;Merck KGaA, Germany;DEU;Companies
17;230;Pfizer Inc, United States;USA;Companies
18;232;VTT Technical Research Centre of Finland;FIN;Companies
18;232;AstraZeneca, United Kingdom;GBR;Companies
20;243;Merck & Co Inc, United States;USA;Companies
21;253;IBM United States;USA;Companies
21;253;Eli Lilly and Company, United States;USA;Companies
23;256;GlaxoSmithKline, United States;USA;Companies
24;269;Siemens AG, USA;USA;Companies
25;275;Takeda Pharmaceutical Co Inc, Japan;JPN;Companies
26;277;Amgen, USA;USA;Companies
27;280;AstraZeneca, United States;USA;Companies
28;286;Novo Nordisk A/S;DNK;Companies
29;293;Celgene Corp;USA;Companies
30;295;AbbVie Inc, United States;USA;Companies
31;301;Siemens AG, Germany;DEU;Companies
32;307;Danone Nederland BV;NLD;Companies
33;308;Siemens Healthineers, USA;USA;Companies
34;315;Boehringer Ingelheim, USA;USA;Companies
35;318;Takeda Pharmaceuticals International Inc, USA;USA;Companies
36;322;Bayer AG, Germany;DEU;Companies
37;335;Janssen Research & Development, LLC;BEL;Companies
38;349;Boehringer Ingelheim GmbH Germany;DEU;Companies
39;369;GlaxoSmithKline, United Kingdom;GBR;Companies
40;371;Novartis, Switzerland;CHE;Companies
41;397;AstraZeneca, Sweden;SWE;Companies
42;400;Daiichi Sankyo Co., Ltd. Japan;JPN;Companies
43;448;Shionogi & Co Ltd;JPN;Companies
44;451;Novartis Pharmaceuticals, United States;USA;Companies
45;452;UCB Pharma SA, Brussels;BEL;Companies
46;458;GlaxoSmithKline, Belgium;BEL;Companies
47;470;Translational Research Institute;AUS;Companies
48;479;Sanofi, Germany;DEU;Companies
49;481;Bayer Corp, USA;USA;Companies
50;502;Astellas Pharma Inc;JPN;Companies
51;520;Pfizer Inc, United Kingdom;GBR;Companies
52;537;IMEC International;BEL;Companies
53;539;BASF, Germany;DEU;Companies
54;544;Procter & Gamble, USA;USA;Companies
55;545;Lockheed Martin Corp *;USA;Companies
56;546;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
57;568;GeneDx;USA;Companies
58;571;Springer Nature, New Zealand;NZL;Companies
59;576;Johnson & Johnson, United States;USA;Companies
60;583;SINTEF Group;NOR;Companies
61;614;RTI Health Solutions;USA;Companies
62;627;Nippon Telegraph and Telephone Corp, Japan;JPN;Companies
63;661;EMMES Corp;USA;Companies
64;680;ARUP Laboratories;USA;Companies